A February 3, 2026 (B.E. 2569) notification from Thailand's Ministry of Public Health has removed one of the more stubborn distribution barriers facing herbal health product companies in the Thai market. Low-risk herbal health products that clear an evidence-based safety assessment can now be sold through modern trade outlets, convenience stores, general retail, and online platforms, channels that were previously off-limits to most herbal-classified products unless the brand stripped out its health-oriented positioning entirely. For any company building a Thailand strategy around herbal supplement or nutraceutical lines, this is worth acting on now rather than filing away for later.
What the Notification Changes
Under the framework that applied before this notification, herbal products carrying health-oriented positioning were largely restricted to pharmacies, specialty health stores, and direct sales, due to regulator concerns about medicinal claims bleeding into general retail. The new notification creates a distinct track for products that pass an evidence-based safety assessment and meet defined low-risk criteria. Eligible products are herbal formulations whose active constituents appear on Thailand's approved herbal ingredient lists, that carry no disease treatment claims, and that have completed the required safety documentation submitted to and acknowledged by Thai FDA. Previously, the only way around the channel restriction was to reclassify a product as a general food item, a move that stripped away any health-related positioning and, with it, much of the product's commercial appeal.
Why This Is a Real Commercial Opening
The most significant practical change is online platform access. Thailand's e-commerce supplement market has expanded considerably, and distribution through platforms like Lazada, Shopee, and LINE Shopping was previously constrained for herbal-classified products. That restriction lifts for qualifying products under this notification, provided advertising on those platforms still complies with Thai FDA's health claim rules. Companies that have already invested in GMP-certified herbal ingredient sourcing and complete safety documentation are best placed to move quickly, since the evidence-based safety assessment is not a new pathway built from scratch. It draws on the same ingredient safety dossier components already required for standard supplement notification, so companies with complete files can evaluate their eligibility without rebuilding their regulatory submissions.
It is worth being precise about scope: eligibility is granted product by product, not category-wide. A brand cannot assume that because one herbal SKU qualifies, its entire portfolio automatically does. Distributors and retail platform teams need to understand this distinction clearly, because listing an ineligible product in a newly opened channel creates compliance exposure that falls back on the brand.
What to Do Before You Expand Channels
Start with a portfolio-level screen: review every herbal supplement product against the notification's criteria, approved ingredient status, absence of disease treatment claims, and current GMP documentation, to identify which SKUs are candidates for channel expansion. For products that pass this initial screen, confirm the underlying dossier actually contains a documented evidence-based safety assessment; an existing Thai FDA notification does not automatically satisfy this requirement on its own. Advertising materials need their own review pass too, since online listings, convenience store point-of-sale materials, and modern trade shelf cards each carry different Thai FDA advertising requirements, and channel-specific copy should be checked against those rules before anything goes live. Finally, brief your distribution partners directly. 3PL providers and retail platform account managers need to know that eligibility is product-specific, and commercial teams should be trained to confirm status before listing anything in a new channel.
DeeMED Consulting reviews existing supplement dossiers for general sale channel eligibility, identifies documentation gaps, and works directly with Thai FDA on classification questions. If your herbal product line is a candidate for this expanded distribution, our dietary supplement registration and notification team can confirm eligibility and close any documentation gaps before your first shipment reaches a new channel.
Sources & Further Reading
- Thai FDA reform expanding herbal product market access, reported by Pattaya Mail — pattayamail.com